Year |
Citation |
Score |
2024 |
Jung D, Long-Boyle JR, Pang WW, Gobburu JVS. Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients with Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia. Transplantation and Cellular Therapy. PMID 38972509 DOI: 10.1016/j.jtct.2024.07.001 |
0.445 |
|
2021 |
Bankova AK, Pang W, Velasco BJ, Long-Boyle JR, Shizuru JA. 5-Azacytidine depletes hematopoietic stem cells and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent mice. Blood Advances. PMID 34448832 DOI: 10.1182/bloodadvances.2020003841 |
0.702 |
|
2019 |
Iliopoulou BP, Hsu K, Pérez-Cruz M, Tang SW, Pang WW, Erkers T, Kambham N, Freeman GJ, Dekruyff RH, Meyer EH. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation. Blood Advances. 3: 3419-3431. PMID 31714958 DOI: 10.1182/Bloodadvances.2019000286 |
0.467 |
|
2019 |
Balogh P, Adelman ER, Pluvinage JV, Capaldo BJ, Freeman KC, Singh S, Elagib KE, Nakamura Y, Kurita R, Sashida G, Zunder ER, Li H, Gru AA, Price EA, Schrier SL, ... ... Pang WW, et al. RUNX3 levels in human hematopoietic progenitors are regulated by aging and dictate erythroid-myeloid balance. Haematologica. PMID 31171641 DOI: 10.3324/Haematol.2018.208918 |
0.627 |
|
2019 |
Pang WW, Czechowicz A, Logan AC, Bhardwaj R, Poyser J, Park CY, Weissman IL, Shizuru JA. Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice. Blood. PMID 30745302 DOI: 10.1182/Blood-2018-06-858159 |
0.841 |
|
2019 |
Czechowicz A, Palchaudhuri R, Scheck A, Hu Y, Hoggatt J, Saez B, Pang WW, Mansour MK, Tate TA, Chan YY, Walck E, Wernig G, Shizuru JA, Winau F, Scadden DT, et al. Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. Nature Communications. 10: 617. PMID 30728354 DOI: 10.1038/S41467-018-08201-X |
0.826 |
|
2019 |
Kwon HS, Logan AC, Chhabra A, Pang WW, Czechowicz A, Tate K, Le A, Poyser J, Hollis R, Kelly BV, Kohn DB, Weissman IL, Prohaska SS, Shizuru JA. Anti-human CD117 antibody-mediated bone marrow niche clearance in non-human primates and humanized NSG mice. Blood. PMID 30617195 DOI: 10.1182/Blood-2018-06-853879 |
0.814 |
|
2018 |
Balogh P, Capaldo B, Singh S, Elagib K, Li H, Zunder E, Figueroa ME, Pang W, Goldfarb A. Dysregulation of RUNX3 in Aged Human HSPCs May Contribute to Perturbations in Erythropoiesis and Balanced Lineage Output Blood. 132: 2553-2553. DOI: 10.1182/Blood-2018-99-115245 |
0.589 |
|
2018 |
Cruz MP, Hsu K, Iliopoulou BP, Erkers T, Pang W, Dekruyff RH, Freeman GJ, Meyer E. Bone Morphogenetic Protein Signaling Pathway Modulation by Blocking Anti-Repulsive Guidance Molecule B Antibody Promotes Tolerance in Graft-Versus-Host Disease Biology of Blood and Marrow Transplantation. 24: S324. DOI: 10.1016/J.Bbmt.2017.12.379 |
0.335 |
|
2018 |
Pang WW, Czechowicz A, Poyser J, Park CY, Weissman IL, Shizuru JA. Anti-Human CD117 Antibodies Mediate Clearance of Myelodysplastic Syndrome Hematopoietic Stem Cells and Facilitate Establishment of Normal Hematopoiesis in Transplantation Biology of Blood and Marrow Transplantation. 24: S230-S231. DOI: 10.1016/J.Bbmt.2017.12.211 |
0.829 |
|
2017 |
Pang WW, Schrier SL, Weissman IL. Age-associated changes in human hematopoietic stem cells. Seminars in Hematology. 54: 39-42. PMID 28088986 DOI: 10.1053/J.Seminhematol.2016.10.004 |
0.557 |
|
2016 |
Weiskopf K, Schnorr PJ, Pang WW, Chao MP, Chhabra A, Seita J, Feng M, Weissman IL. Myeloid Cell Origins, Differentiation, and Clinical Implications. Microbiology Spectrum. 4. PMID 27763252 DOI: 10.1128/Microbiolspec.Mchd-0031-2016 |
0.824 |
|
2015 |
Rolls A, Pang WW, Ibarra I, Colas D, Bonnavion P, Korin B, Heller HC, Weissman IL, de Lecea L. Sleep disruption impairs haematopoietic stem cell transplantation in mice. Nature Communications. 6: 8516. PMID 26465715 DOI: 10.1038/Ncomms9516 |
0.772 |
|
2013 |
Lavender KJ, Pang WW, Messer RJ, Duley AK, Race B, Phillips K, Scott D, Peterson KE, Chan CK, Dittmer U, Dudek T, Allen TM, Weissman IL, Hasenkrug KJ. BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection. Blood. 122: 4013-20. PMID 24021673 DOI: 10.1182/Blood-2013-06-506949 |
0.736 |
|
2013 |
Pang WW, Pluvinage JV, Price EA, Sridhar K, Arber DA, Greenberg PL, Schrier SL, Park CY, Weissman IL. Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes. Proceedings of the National Academy of Sciences of the United States of America. 110: 3011-6. PMID 23388639 DOI: 10.1073/Pnas.1222861110 |
0.753 |
|
2013 |
Pang WW, Pluvinage JV, Mori Y, Price E, Wickrema A, Adensina O, Artz A, Weissman IL, Schrier SL. Unexplained Anemia In The Elderly Is Due To An Intrinsic Defect In Hematopoietic Stem Cells Blood. 122: 2187-2187. DOI: 10.1182/Blood.V122.21.2187.2187 |
0.652 |
|
2013 |
Park C, Pang W, Chung S, Pluvinage J, Price E, Sridhar K, Arber D, Greenberg P, Schrier S, Weissman I. O-009 Evaluation of hematopoietic stem/progenitor cells in MDS reveals novel pathogenic mechanisms Leukemia Research. 37: S12-S13. DOI: 10.1016/S0145-2126(13)70031-6 |
0.644 |
|
2013 |
Chung S, Pang W, Jan M, Klimek V, Weissman I, Majeti R, Park C. CD99 identifies disease stem cells in acute myeloid leukemia (AML) and the myelodysplastic syndromes (MDS) Experimental Hematology. 41: S16. DOI: 10.1016/J.Exphem.2013.05.060 |
0.787 |
|
2013 |
Rolls A, Pang W, Ibarra I, Colas D, Bonnavion P, Heller H, Weissman I, Lecea L. 20. Sleep regulates hematopoietic stem cell trafficking Brain, Behavior, and Immunity. 32: e6. DOI: 10.1016/J.Bbi.2013.07.032 |
0.776 |
|
2012 |
Raval A, Kusler B, Pang WW, Weissman IL, Mitchell BS, Park CY. Effect of nucleophosmin1 haploinsufficiency on hematopoietic stem cells. Leukemia. 26: 853-5. PMID 21979879 DOI: 10.1038/Leu.2011.270 |
0.672 |
|
2012 |
Chung SS, Pang WW, In GK, Jan M, Klimek VM, Melnick A, Weissman IL, Majeti R, Park CY. CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes Blood. 120: 210-210. DOI: 10.1182/Blood.V120.21.210.210 |
0.754 |
|
2011 |
Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, Schrier SL, Weissman IL. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proceedings of the National Academy of Sciences of the United States of America. 108: 20012-7. PMID 22123971 DOI: 10.1073/Pnas.1116110108 |
0.773 |
|
2011 |
McGowan KA, Pang WW, Bhardwaj R, Perez MG, Pluvinage JV, Glader BE, Malek R, Mendrysa SM, Weissman IL, Park CY, Barsh GS. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood. 118: 3622-33. PMID 21788341 DOI: 10.1182/Blood-2010-11-318584 |
0.612 |
|
2011 |
Park CY, Pang WW, Price E, Pluvinage JA, Schrier SL, Weissman IL. Hematopoietic Stem Cells Are the Disease-Initiating Cells in the Myelodysplastic Syndromes Blood. 118: 789-789. DOI: 10.1182/Blood.V118.21.789.789 |
0.75 |
|
2011 |
Czechowicz A, Bhardwaj R, Pang W, Park C, Weissman I. Targeted Clearance of Human Hematopoietic Stem Cell Niches Via Inhibition of SCF Signaling Using Monoclonal Antibody SR-1 Biology of Blood and Marrow Transplantation. 17: S187-S188. DOI: 10.1182/Blood.V116.21.74.74 |
0.835 |
|
2010 |
Pang W, Price E, Weissman IL, Schrier SL. Characterization of Hematopoietic Stem Cell Frequency and Function In Unexplained Anemia of the Elderly Blood. 116: 2047-2047. DOI: 10.1182/Blood.V116.21.2047.2047 |
0.674 |
|
2009 |
Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD, van Rooijen N, Weissman IL. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 138: 286-99. PMID 19632179 DOI: 10.1016/J.Cell.2009.05.045 |
0.819 |
|
2009 |
Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 138: 271-85. PMID 19632178 DOI: 10.1016/J.Cell.2009.05.046 |
0.816 |
|
2009 |
Cao TM, Lazzeroni LC, Tsai S, Pang WW, Kao A, Camp NJ, Thomas A, Shizuru JA. Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice. Journal of Immunology (Baltimore, Md. : 1950). 183: 462-9. PMID 19525392 DOI: 10.4049/Jimmunol.0900454 |
0.558 |
|
2009 |
Raval A, Park CY, Pang WW, Kusler B, Sridhar KJ, Gotlib JR, Greenberg PL, Weissman IL, Mitchell BS. NPM1 Haploinsufficiency Results in Increased Numbers of Hematopoietic Stem Cells and Progenitor Cells. Blood. 114: 738-738. DOI: 10.1182/Blood.V114.22.738.738 |
0.751 |
|
2009 |
Park CY, Pang WW, Greenberg PL, Weissman IL. Myelodysplastic Syndromes Are Characterized by Gene Expression Changes in Hematopoietic Stem Cells and Alterations in Hematopoietic Stem Cell and Myeloid Progenitor Composition. Blood. 114: 1762-1762. DOI: 10.1182/Blood.V114.22.1762.1762 |
0.764 |
|
2009 |
Pang WW, Price EA, Weissman IL, Schrier SL. Hematopoiesis in the Elderly: Age-Associated Effects in Frequency, Function, and Gene Expression of Human Hematopoietic Stem Cells. Blood. 114: 1505-1505. DOI: 10.1182/Blood.V114.22.1505.1505 |
0.685 |
|
2009 |
Majeti R, Chao MP, Alizadeh AA, Pang WW, Jaiswal S, Gibbs KD, Weissman IL. Abstract CN07-03: CD47 is an adverse prognostic factor and therapeutic antibody target on human AML stem cells Molecular Cancer Therapeutics. 8. DOI: 10.1158/1535-7163.Targ-09-Cn07-03 |
0.817 |
|
2008 |
Majeti R, Chao MP, Alizadeh AA, Pang WW, Weissman IL. CD47 Is An Independent Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells Blood. 112: 766-766. DOI: 10.1182/Blood.V112.11.766.766 |
0.762 |
|
2006 |
Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, Mills KD, Patel P, Hsu JT, Hong AL, Ford E, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 124: 315-29. PMID 16439206 DOI: 10.1016/J.Cell.2005.11.044 |
0.3 |
|
2004 |
Cao TM, Pang WW, Grumet FC, Lazzeroni LC, Shizuru JA. Genetic Susceptibility Loci for Lethal Graft-Versus-Host Disease in MHC-Identical Mice: Initial Results from a Genome-Wide Scan. Blood. 104: 4986-4986. DOI: 10.1182/Blood.V104.11.4986.4986 |
0.557 |
|
Show low-probability matches. |